DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/lzszsl/global) has announced the addition of the "Global Schizophrenia Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Schizophrenia epidemiology, Schizophrenia diagnosed patients, and Schizophrenia treatment rate for the top seven pharmaceutical markets. The study measures key indicators such as prevalence of Schizophrenia derived from epidemiological analysis, percentage of patients diagnosed with Schizophrenia, and percentage of patients treated with Schizophrenia therapy.
The study helps executives estimate Schizophrenia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Schizophrenia prevalence, Schizophrenia diagnosis rate, and Schizophrenia treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Schizophrenia: Disease Definition
2. Global Schizophrenia Patient Flow
3. Schizophrenia Patient Flow in the US
4. Schizophrenia Patient Flow in Europe
5. Schizophrenia Patient Flow in Germany
6. Schizophrenia Patient Flow in France
7. Schizophrenia Patient Flow in Spain
8. Schizophrenia Patient Flow in Italy
9. Schizophrenia Patient Flow in UK
10. Schizophrenia Patient Flow in Japan
For more information visit http://www.researchandmarkets.com/research/lzszsl/global.